Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Lifespan.io (LEAF)
Supporting the development of biotechnologies focused on ending age-related diseases
Non-profit with a mission to promote the advancement of biomedical technologies which will increase healthy human lifespan. By sponsoring and democratizing research efforts through crowdfunding, crowdsourcing, and engaging the public in thoughtful dialogue, we aim to accelerate the achievement of this important goal for all humankind.
Previously known as Life Extension Advocacy Foundation.
Initial founders:
- Keith Comito
- Oliver Medvedik
- Richard Kaufman
- Apneet Jolly
Visit website: https://www.lifespan.io/
Details last updated 03-May-2019
Lifespan.io (LEAF) Blog Posts
10-Sep-2020
Lifespan.io (LEAF) Creations
Ending Age-Related Diseases 2023
10-Aug-2023 to 11-Aug-2023
Longevity+DeSci Summit NYC brings the best longevity researchers and biotech investors together organized by Lifespan.io
Why Political Action Matters for Longevity - Dylan Livingston at Ending Age-Related Diseases 2022
Dylan Livingston of the Alliance for Longevity Initiatives explains why political longevity activism needs to exist (YouTube)
Ending Age-Related Diseases 2022
11-Aug-2022 to 14-Aug-2022
Virtual Conference for Rejuvenation Biotechnology and Life Extension organized by Lifespan Extension Advocacy Foundation
Ending Age-Related Diseases (EARD) 2021
19-Aug-2021 to 22-Aug-2021
Hear the latest developments from the leading experts in rejuvenation biotechnology research
Ask Me Anything (AMA) with The PEARL Team
28-May-2021
Find out more about the Participatory Evaluation of Aging with Rapamycin for Longevity Study (FREE)
A Summary of Spermidine
lifespan.io summarises how it is created and the latest research into its geroprotective properties
People at Lifespan.io (LEAF)
Oliver Medvedik
Director of The Maurice Kanbar Center for Biomedical Research and Vice President of LEAF.
Lifespan.io (LEAF) News
Dr. Sajad Zalzala reports on PEARL rapamycin trial results
Live Forever Club - 28-Aug-2024Safety of rapamycin looks good and lean muscle mass among biomarkers trending towards improvement
Lifespan.io crowd-funds clinical trial to determine the effects of Rapamycin
Lifespan.io (LEAF) - 17-May-2021PEARL: Participatory Evaluation of Aging with Rapamycin for Longevity
Irina Conboy explains latest blood plasma dilution results to lifespan.io Journal Club
Live Forever Club - 27-Jan-2021Conboys are planning a modified lifespan study - looking for funding
Major mouse senolytics testing experiment is go!
Lifespan.io (LEAF) - 13-Apr-2020We'll almost certainly need a combination of drugs so look forward to seeing the results
Interview with LEAF's Elena Milova
Medium - 09-Jan-2020Education and funding are essential to enable radical life extension in the next 20 years
Developmental stages of anti-ageing treatments
Next Big Future - 09-Jun-2019Two anti-ageing treatments in phase 3 clinical trials and four in phase 2 clinical trials
Crowdfunding NAD+ Mouse Lifespan Study
Lifespan.io (LEAF) - 18-Sep-2018This project aims to observe if the NAD+ precursor has a positive effect over aging mice
